Bank of America’s Spruce Biosciences SPRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-93
Closed -$8.1K 7202
2025
Q4
$8.1K Buy
93
+90
+3,000% +$9.64K ﹤0.01% 6199
2025
Q3
$27 Buy
+3
New +$27 ﹤0.01% 8133
2025
Q2
Sell
-3
Closed -$68 8767
2025
Q1
$68 Hold
3
﹤0.01% 7908
2024
Q4
$93 Hold
3
﹤0.01% 7753
2024
Q3
$106 Buy
3
+1
+50% +$37 ﹤0.01% 7713
2024
Q2
$78 Sell
2
-346
-99% -$18.6K ﹤0.01% 7759
2024
Q1
$20.5K Buy
+348
New +$88.5K ﹤0.01% 6748
2023
Q4
Sell
-4
Closed -$462 7554
2023
Q3
$701 Buy
+4
New +$674 ﹤0.01% 7282
2023
Q2
Sell
-3
Closed -$550 8003
2023
Q1
$550 Buy
+3
New +$557 ﹤0.01% 7361
2022
Q4
Sell
-18
Closed -$1.51K 8062
2022
Q3
$2K Sell
18
-20
-53% -$2.79K ﹤0.01% 7598
2022
Q2
$5K Sell
38
-27
-42% -$3.46K ﹤0.01% 7599
2022
Q1
$10K Sell
65
-1,043
-94% -$194K ﹤0.01% 7753
2021
Q4
$371K Buy
1,108
+884
+395% +$263K ﹤0.01% 6111
2021
Q3
$102K Buy
224
+119
+113% +$74.7K ﹤0.01% 6714
2021
Q2
$88K Sell
105
-67
-39% -$71.5K ﹤0.01% 6585
2021
Q1
$214K Buy
172
+151
+719% +$232K ﹤0.01% 5985
2020
Q4
$39K Buy
+21
New +$34.8K ﹤0.01% 6415

Other funds holding SPRB

Bank of America's SPRB Position: Q1 2026 in Review

Bank of America sold out of Spruce Biosciences (SPRB) in Q1 2026, closing a stake of 93 shares — an estimated $8.1K sold.

Bank of America first reported a position in SPRB in Q4 2020 and held it in 17 quarters. The position peaked at $371K in Q4 2021. 32 funds tracked by Wall St. Rank hold SPRB as of Q1 2026.

  • Bank of America reported no remaining Spruce Biosciences position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 93 Spruce Biosciences shares in Q1 2026, an estimated $8.1K.
  • Bank of America first reported a position in Spruce Biosciences in Q4 2020 and held it in 17 quarters.
  • Bank of America's Spruce Biosciences position peaked at $371K in Q4 2021.
  • 32 funds tracked by Wall St. Rank held Spruce Biosciences as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.